30 results about "Anxiety state" patented technology

The embodiment of the invention provides an anxiety state detecting method and device, and relates to the technical field of medical electronics. The method comprises the steps of obtaining three-dimensional acceleration data of a user; then judging whether the three-dimensional acceleration data of the user satisfies a condition of false anxiety features or not after it is detected that the usershows anxiety physiological features, and if not, determining that the user is in the anxiety state. In this way, the three-dimensional acceleration data is utilized to exclude the false anxiety features, thus a true anxiety state of the user is accurately obtained, and the user is reminded to take measures as early as possible to improve the health.

An embodiment of the invention discloses an early warning method, device and equipment for an anxiety state and a storage medium. The method comprises the following steps: acquiring resting state data of a monitored user in real time by wearing equipment; if the monitored user is determined to be in the anxiety state according to the resting state data of the monitored user, carrying out anxiety early warning on the monitored user. By the method, the anxiety state of the monitored user can be judged objectively, early warning reminding on the monitored user is carried out when determining that the monitored user is in the anxiety state, then the monitored user can take some measures to soothe the anxiety, and the circumstance that the monitored user remains in the anxiety state for a long time to affect health is avoided.

The invention relates to the field of animal models, in particular to a construction method of a psoriasis animal model. The construction method comprises the application of imiquimod to induce psoriasis-like lesions in an anxious animal. The constructed mice can not only reflect the anxiety state of clinical patients, but also aggravate the psoriasis-like lesions, and prolong the maintenance timeof psoriasis-like lesions induced by imiquimod.

The invention discloses a traditional Chinese medicine preparation for treating the FD (Functional Dyspepsia) with a depression and anxiety state. In the traditional Chinese medicine, the FD generally belongs to the scopes of stomachache, distention and fullness of the traditional Chinese medicine according to the characteristics of symptoms of the FD, and the most common symptoms of the FD include spleen deficiency, qi stagnation, liver-stomach disharmony, liver stagnation and spleen deficiency. The traditional Chinese medicines, namely jasminum grandiflorum, begonia yunnanensis, cyperus michelianus, habenaria buchneroides, polyalthia nemoralis, cicerbita cyanea, castanopsis hystrix, flos mume, plagiopus oederi and rhodobryum roseum are selected and decocted into a decoction with water. Clinical tests show that the total effective rate of the traditional Chinese medicine preparation reaches 90% and is obviously superior to that of a control group.

The invention provides a speech-based anxiety prediction model generation method and an anxiety prediction system, and the method comprises the steps: 1, collecting speech of a text read by the user and the SAS scale score of the user, and marking the speech with the score; and 2, extracting voice features of the voice, and constructing an anxiety prediction model by using a neural network. According to the invention, automatic recognition of the tested anxiety state is realized through machine learning by using the voice of the reading text, the system is convenient to operate and deploy, andthe anxiety recognition and prediction convenience is improved.

The invention aims to provide a traditional Chinese medicine for improving postoperative anxiety state in patients with thyroid cancer. The traditional Chinese medicine is prepared from radix bupleuri, radix scutellariae, pericarpium citri reticulatae, pinellia ternata, bamboo shavings, fructus aurantii immaturus, radix gentianae, fructus gardeniae, cassia seed, chrysanthemum, white paeony root, radix rehmanniae, tuber fleeceflower stem, magnet, mother of pearl, rhizoma nelumbinis, leech, centipede, spina gleditsiae, Chinese prickly ash, liquorice, spica prunellae, seaweed, poria cocos and white atractylodes rhizome. The traditional Chinese medicine is prepared by the steps: mixing the traditional Chinese medicines together, adding water, soaking for half an hour, boiling with high heat, then changing to gentle heat, decocting for 30 min, and filtering to obtain a first filtrate; adding water to the filter residue, boiling with high heat, then changing to gentle heat, decocting for 30min, and filtering to obtain a second filtrate; and mixing the two filtrates evenly, concentrating to 200-300 mL, and thus obtaining the product. The traditional Chinese medicine is prepared by the pure traditional Chinese medicines, has the efficacies of clearing liver and purging fire, activating blood circulation and removing blood stasis, preventing and delaying the recurrence and metastasis of thyroid cancer, is an innovation in medicines of postoperative rehabilitation treatment for thyroid cancer, and has remarkable economic and social benefits.

The embodiment of the invention discloses a determining method, device and equipment of an anxiety state and a storage medium. The determining method comprises the steps that resting state data of a user to be detected is acquired; according to the resting state data, function linkage intensity between a nucleus accumbens brain area and one or more first selected brain areas around the nucleus accumbens brain area of the user to be detected is calculated; if it is determined that the function linkage intensity meets a first anxiety condition, LFP signals of one or more target brain areas of the user to be detected are acquired; if it is determined that theta rhythms of the LFP signals of the target brain areas meet a second anxiety condition, it is determined that the user to be detected is in the anxiety state. According to the embodiment, the method for objectively evaluating the anxiety state of the user is provided and solves the problem of existence of subjective factors in evaluation of the anxiety state of the user to be detected in the prior art.

The invention discloses a device for examining anxiety degrees on the basis of LZC (Lemp-Ziv complexity). The device comprises electroencephalography signal acquisition equipment, a preprocessing module, an analysis and computation module and a classification module. The electroencephalography signal acquisition equipment is used for acquiring EEG (electroencephalography) signals in 8-minute eye-open and eye-closed rest states; the preprocessing module is used for extracting four frequency bands delta, theta, alpha and beta of the EEG signals after processing such as down-sampling, filtering and artifact removing is carried out on the EEG signals; the analysis and computation module is used for nonlinearly analyzing LZC for the four frequency bands of the EEG signals, sequentially computing LZC values of the four frequency bands by the aid of split time sequences used as units, and computing anxiety coefficients according to the obtained LZC values of the four frequency bands, and theobtained anxiety-free, mild-anxiety and moderate and severe-anxiety coefficients can be used as judgment indexes for examining the anxiety degrees; the classification module is used for applying support vector machines to building anxiety degree classification models by the aid of input data which are anxiety coefficient characteristic matrixes of anxiety-free, mild-anxiety and moderate and severe-anxiety crowds, and the anxiety coefficient characteristic matrixes are obtained after LZC characteristics of various leads are extracted, so that an anxiety-free state, a mild-anxiety state and a moderate and severe-anxiety state can be accurately, objectively and automatically classified.

The embodiment of the invention discloses a multi-user emotion monitoring method and device, equipment and a storage medium. The method comprises the steps that anxiety states of two or more monitoring users in a user cluster are monitored and set; if it is determined that in a set time interval, the number of users which have anxiety states is beyond a set user number threshold value, a group emotion relieving strategy is adopted to adjust group emotions of the user cluster. According to the multi-user emotion monitoring method, when it is monitored that multiple users have the anxiety states in the user cluster, the group emotion relieving strategy is adopted to adjust the group emotions of the user cluster, and the situation is effectively avoided that the user cluster anxiety phenomenon is caused by continuous group activities.

The invention belongs to the technical field of health-care food, and particularly relates to a folic acid-containing anxiety-relieving product. The folic acid-containing anxiety-relieving product comprises the following components of a folic acid compound, ginkgo leaves, Chinese wolfberry and lotus seeds. The folic acid-containing anxiety-relieving product has a remarkable anxiety-resisting effect, does not have toxic or side effect, tastes good, is extremely suitable for modern people who have high pressure and are often in an anxiety state to eat as leisure food, can effectively relieve anxiety of people, and is beneficial to physical and psychological health.

The invention discloses a ligusticum wallichii brain clearing analgesia capsule and a preparation method of the ligusticum wallichii brain clearing analgesia capsule. The raw material of the ligusticum wallichii brain clearing analgesia capsule comprises, by weight, 25% of ligusticum wallichii, 10%-12% of gastrodia elata, 8%-10% of asarum, 10%-12% of radix angelicae, 10%-12% of pseudo-ginseng, 13%-15% of kudzuvine roots and 18%-20% of white paeony roots, and the brain clearing analgesia capsule is prepared through crushing, extraction and mixing. A curative effect is achieved on cluster headache syndrome after the capsule is taken once, a symptom can be relieved in short time when capsules are taken continuously, the effect of treating the symptom and the root can be achieved if capsules are taken consistently, any side effect or dependency is avoided, and obvious effects are achieved on psychosomatic diseases such as an anxiety state, nerve transient tic disorder, neurasthenia, hypertension, colitis, coronary heart disease, asthma and gastric ulcer.

Disclosed is a composition comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and the corresponding use and method comprising the administration of alprazolam sublingual tablets having a disintegration time lower than 30 seconds and having the alprazolam preferably in non-crystalline or partially crystalline form according to the X-ray diffraction crystallography expanded for the position delta 9-12.5 (2 theta), to a patient suffering from said disorder. There is also disclosed a method for preparing a composition according to the invention, where the alprazolam is solved in a pharmaceutical acceptable solvent and a binder, preferably polyvinylpyrrolidone, is incorporated to the solution. A pre-made mixture of part of the cross-linked carboxymethyl-cellulose and the rest of the ingredients of the composition is impregnated with the solution and is dried and grinded, and is added to the rest of the cross-linked carboxymethyl-cellulose and the flavoring additives, being then mixed and compressed.

The invention discloses a brain clearing and pain easing Chinese medicinal capsule and a preparation method thereof. The method consists of: taking 25% of Ligusticum wallichii, 10%-12% of rhizoma gastrodiae, 8%-10% of asarum, 10%-12% of angelica dahurica, 10%-12% of panax notoginseng, 13%-15% of Kudzuvine Root, and 18%-20% of white paeony root as the raw materials, and conducting crushing, extraction and mixing to prepare the brain clearing and pain easing Chinese medicinal capsule. Once taking of the capsule can achieve certain efficacy on angioneurotic headache, continuous taking of the capsule can alleviate symptoms within a short period of time, and persistent taking of the capsule can achieve the effects of treating both symptoms and root causes. Also, the capsule has no side effect or dependence, and also can achieve significant curative effect on anxiety state, nervous tics, neurasthenia, high blood pressure, colitis, coronary heart disease, asthma, gastric ulcer and other psychosomatic diseases.

Disclosed is a method and system for monitoring a separation anxiety of a pet that may recognize an activity of the pet using a support vector machine (SVM) based on pet-related data acquired from a sensor, and may determine whether the pet is in a separation anxiety state by analyzing input data that is the recognized activity of the pet using a complex event processing (CEP).

The invention discloses application of miltefosine and pharmaceutically acceptable salts thereof in preparation of drugs for treating neurodegenerative diseases related to memory, cognitive function and anxiety, including Alzheimer's disease. A large number of experimental screening results show that the miltefosine and the pharmaceutically acceptable salts thereof can improve memory and cognitive dysfunction and anxiety states of 3xTg-AD model mice in behavioral experiments of new object recognition, Y-maze, elevated plus maze and Morris water maze.